gvtcx

supplier · GB-PPONPRVD-4666-TRCN

Glenmark Pharmaceuticals Europe Ltd

WD188YA combined from 3 published records

Glenmark Pharmaceuticals Europe Ltd has won 80 UK public sector awards from 10 buyers since 2019. The typical award is worth £37,691,041.

as a supplier

80 recorded awards from 10 buyers , between 30 Apr 2019 and 26 Aug 2026.

awards won
80
exclusive
1%
1 sole-winner awards
median award
£37.7m
largest
£469.7m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Glenmark Pharmaceuticals Europe Ltd

How many public sector contracts has Glenmark Pharmaceuticals Europe Ltd won?

Glenmark Pharmaceuticals Europe Ltd has won 80 UK public sector contracts from 10 public bodies since 2019.

Which public bodies buy from Glenmark Pharmaceuticals Europe Ltd?

Glenmark Pharmaceuticals Europe Ltd has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") and The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority").

How large are Glenmark Pharmaceuticals Europe Ltd's contracts?

The median published value of a contract won by Glenmark Pharmaceuticals Europe Ltd is £37,691,041. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Glenmark Pharmaceuticals Europe Ltd contracts are expiring soon?

3 contracts involving Glenmark Pharmaceuticals Europe Ltd have end dates in the next 12 months, the earliest on 31 May 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £393,331,872 26 Aug 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £35,010,320 30 Apr 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
NHS National Framework for Transition Products (Nintedanib and Dalbavancin) shared NHS England £14,758,000 25 Feb 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin shared NHS England £25,881,000 25 Nov 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS National Framework for Transition products commencing 1 October 2024 shared NHS England £16,224,000 29 Sept 2024
NHS National Framework for Transition products commencing 1 May 2024 shared NHS England £7,559,000 15 Apr 2024
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 shared NHS England £1,009,500,000 4 Apr 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS National Generic Pharmaceuticals Wave 14a shared NHS England £207,982,407 14 Dec 2022
NHS National Pharmaceuticals Transition 2022_2 shared NHS England £35,745,737 1 Nov 2022
NHS National Generic Pharmaceuticals - Lenalidomide shared NHS England £1 30 Aug 2022
NHS National Pharmaceuticals Transition 2022_1 shared NHS England £39,636,345 18 Jul 2022
NHS Framework Agreement for Branded Medicines - National shared NHS England £526,000,000 15 May 2022
National Procurement for HIV and Preventative Treatments shared NHSE&I £230,000,000 1 Feb 2022
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,518 30 Nov 2021
NHS National Pharmaceuticals Transition 2021_3 shared NHS England £25,983,607 21 Oct 2021
NHS Framework Agreement for Branded Medicines - National shared NHS England £95,224,871 26 Sept 2021
NHS National Generic Pharmaceuticals Interim 2 shared NHS England £12,327,097 21 Dec 2020

every contract won by Glenmark Pharmaceuticals Europe Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Glenmark Pharmaceuticals Europe Limited · WD18 8YA 68
Glenmark Pharmaceuticals Europe Ltd GB-COH 05040260 WD18 8YA 7
Glenmark Pharmaceuticals Europe Limited GB-PPON PRVD-4666-TRCN HA3 0BU 5

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 3 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.